Cargando…

Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy

There are numerous mathematical models simulating the behaviour of cancer by considering variety of states in different treatment strategies, such as chemotherapy. Among the models, one is developed which is able to consider the blood vessel‐production (angiogenesis) in the vicinity of the tumour an...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalili, Pariya, Zolatash, Sareh, Vatankhah, Ramin, Taghvaei, Sajjad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675840/
https://www.ncbi.nlm.nih.gov/pubmed/33491873
http://dx.doi.org/10.1049/syb2.12010
_version_ 1784615957002452992
author Khalili, Pariya
Zolatash, Sareh
Vatankhah, Ramin
Taghvaei, Sajjad
author_facet Khalili, Pariya
Zolatash, Sareh
Vatankhah, Ramin
Taghvaei, Sajjad
author_sort Khalili, Pariya
collection PubMed
description There are numerous mathematical models simulating the behaviour of cancer by considering variety of states in different treatment strategies, such as chemotherapy. Among the models, one is developed which is able to consider the blood vessel‐production (angiogenesis) in the vicinity of the tumour and the effect of anti‐angiogenic therapy. In the mentioned‐model, normal cells, cancer cells, endothelial cells, chemotherapy and anti‐angiogenic agents are taking into account as state variables, and the rate of injection of the last two are considered as control inputs. Since controlling the cancerous tumour growth is a challenging matter for patient's life, the time schedule design of drug injection is very significant. Two optimal control strategies, an open‐loop (calculus of variations) and a closed‐loop (state‐dependent Riccati equation), are applied on the system in order to find an optimal time scheduling for each drug injection. By defining a proper cost function, an optimal control signal is designed for each one. Both obtained control inputs have reasonable answers, and the system is controlled eventually, but by comparing them, it is concluded that both methods have their own benefits which will be discussed in details in the conclusion section.
format Online
Article
Text
id pubmed-8675840
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86758402022-02-16 Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy Khalili, Pariya Zolatash, Sareh Vatankhah, Ramin Taghvaei, Sajjad IET Syst Biol Original Research Papers There are numerous mathematical models simulating the behaviour of cancer by considering variety of states in different treatment strategies, such as chemotherapy. Among the models, one is developed which is able to consider the blood vessel‐production (angiogenesis) in the vicinity of the tumour and the effect of anti‐angiogenic therapy. In the mentioned‐model, normal cells, cancer cells, endothelial cells, chemotherapy and anti‐angiogenic agents are taking into account as state variables, and the rate of injection of the last two are considered as control inputs. Since controlling the cancerous tumour growth is a challenging matter for patient's life, the time schedule design of drug injection is very significant. Two optimal control strategies, an open‐loop (calculus of variations) and a closed‐loop (state‐dependent Riccati equation), are applied on the system in order to find an optimal time scheduling for each drug injection. By defining a proper cost function, an optimal control signal is designed for each one. Both obtained control inputs have reasonable answers, and the system is controlled eventually, but by comparing them, it is concluded that both methods have their own benefits which will be discussed in details in the conclusion section. John Wiley and Sons Inc. 2021-01-25 /pmc/articles/PMC8675840/ /pubmed/33491873 http://dx.doi.org/10.1049/syb2.12010 Text en © 2021 The Authors. IET Systems Biology published by John Wiley & Sons Ltd on behalf of The Institution of Engineering and Technology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Papers
Khalili, Pariya
Zolatash, Sareh
Vatankhah, Ramin
Taghvaei, Sajjad
Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy
title Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy
title_full Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy
title_fullStr Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy
title_full_unstemmed Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy
title_short Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy
title_sort optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy
topic Original Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675840/
https://www.ncbi.nlm.nih.gov/pubmed/33491873
http://dx.doi.org/10.1049/syb2.12010
work_keys_str_mv AT khalilipariya optimalcontrolmethodsfordrugdeliveryincanceroustumourbyantiangiogenictherapyandchemotherapy
AT zolatashsareh optimalcontrolmethodsfordrugdeliveryincanceroustumourbyantiangiogenictherapyandchemotherapy
AT vatankhahramin optimalcontrolmethodsfordrugdeliveryincanceroustumourbyantiangiogenictherapyandchemotherapy
AT taghvaeisajjad optimalcontrolmethodsfordrugdeliveryincanceroustumourbyantiangiogenictherapyandchemotherapy